Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group.
Corn, B W
Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group. [electronic resource] - Urology Sep 1999 - 495-502 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
1527-9995
10.1016/s0090-4295(99)00186-7 doi
Adenocarcinoma--blood
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal--therapeutic use
Combined Modality Therapy
Disease-Free Survival
Follow-Up Studies
Goserelin--therapeutic use
Humans
Male
Middle Aged
Prospective Studies
Prostate-Specific Antigen--blood
Prostatic Neoplasms--blood
Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group. [electronic resource] - Urology Sep 1999 - 495-502 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
1527-9995
10.1016/s0090-4295(99)00186-7 doi
Adenocarcinoma--blood
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal--therapeutic use
Combined Modality Therapy
Disease-Free Survival
Follow-Up Studies
Goserelin--therapeutic use
Humans
Male
Middle Aged
Prospective Studies
Prostate-Specific Antigen--blood
Prostatic Neoplasms--blood